RICERCA
AUTORI
RIVISTE
Sfoglia per AUTORE
BRADY K
Collezione AO Cuneo
Items : 1
Phase 3 study of brentuximab vedotin plus doxorubicin, vinblastine, and dacarbazine (A+AVD) versus doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) as front-line treatment for advanced classical Hodgkin lymphoma (HL): Echelon-1 study in Journal of Clinical Oncology
2014
AO Cuneo
Ansell SM; Younes A; Connors JM; Gallamini A; Kim WS; Friedberg JW; Feldman TA; Collins G; Bartlett N; Wang J; Brady K; Sachs J; Huebner D; Hunder NNH; Radford J;